loading

Marinus Pharmaceuticals Inc Stock (MRNS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
6.80%
7.679
7.19 7.338 6.081 10.38
Operating Expenses
2.05%
43.50
42.63 38.98 37.52 43.34
Interest Income/Expense
1.12%
4.346
4.298 4.242 4.208 4.147
Benefits Costs and Expenses
5.33%
46.35
48.96 40.31 39.55 45.11
Costs And Expenses
2.05%
43.50
42.63 38.98 37.52 43.34
Operating Income/Loss
1.08%
-35.82
-35.44 -31.65 -31.44 -32.96
Income/Loss From Continuing Operations Before Tax
7.42%
-38.67
-41.77 -32.97 -33.47 -34.73
Income/Loss From Continuing Operations After Tax
7.42%
-38.67
-41.77 -32.97 -31.93 -34.73
Net Income/Loss
7.42%
-38.67
-41.77 -32.97 -31.93 -34.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,634%
56.85
0.9914 53.92 52.55 51.77
Diluted Average Shares
5,634%
56.85
0.9914 53.92 52.55 51.77
Basic Earnings Per Share
8.11%
-0.68
-0.74 -0.61 -0.61 -0.67
Diluted Earnings Per Share
8.11%
-0.68
-0.74 -0.61 -0.61 -0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):